Xanthones from Securidaca inappendiculata antagonized the antirheumatic effects of methotrexate in vivo by promoting its secretion into urine.

References

• Smolen JS, Aletaha D. Developments in the clinical understanding of rheumatoid arthritis. Arthritis Res Ther. 2009;11:204.
   PubMed Web of Science ®Google Scholar
• Bedoui Y, Guillot X, Sélambarom J, et al. Methotrexate an old drug with new tricks. Int J Mol Sci. 2019;20:5023.
   PubMed Web of Science ®Google Scholar
• Iannone F, Lopalco G, Cantarini L, et al. Efficacy and safety of combination therapy for preventing bone damage in rheumatoid arthritis. Clin Rheumatol. 2016;35:19–23.
   PubMed Web of Science ®Google Scholar
• Cronstein BN. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev. 2005;57:163–172.
   PubMed Web of Science ®Google Scholar
• Huang R, Pan H, Wu J, et al. Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: a randomized controlled clinical trial. Phytomedicine. 2019;57:403–410.
   PubMed Web of Science ®Google Scholar
• Bejarano V, Conaghan PG, Quinn MA, et al. Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis. Rheumatology. 2010;49:1971–1974.
   PubMed Web of Science ®Google Scholar
• Markenson JA. Using the new biologic therapies in rheumatoid arthritis: practical aspects. Future Rheumatol. 2007;2:475–483.
   Google Scholar
• Devine EB, Alfonso-Cristancho R, Sullivan SD. Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach. Pharmacotherapy. 2011;31:39–51.
   PubMed Web of Science ®Google Scholar
• Chen L, Qi H, Jiang D, et al. The new use of an ancient remedy: a double-blinded randomized study on the treatment of rheumatoid arthritis. Am J Chin Med. 2013;41:263–280.
   PubMed Web of Science ®Google Scholar
• Zuo J, Xia Y, Li X, et al. Therapeutic effects of dichloromethane fraction of Securidaca inappendiculata on adjuvant-induced arthritis in rat. J Ethnopharmacol. 2014;153:352–358.
   PubMed Web of Science ®Google Scholar
• Zuo J, Xia Y, Li X, et al. Xanthones from Securidaca inappendiculata exert significant therapeutic efficacy on adjuvant-induced arthritis in mice. Inflammation. 2014;37:908–916.
   PubMed Web of Science ®Google Scholar
• Zuo J, Xia Y, Mao KJ, et al. Xanthone-rich dichloromethane fraction of Securidaca inappendiculata, the possible antirheumatic material base with anti-inflammatory, analgesic, and immunodepressive effects. Pharm Biol. 2014;52:1367–1373.
   PubMed Web of Science ®Google Scholar
• Jiang H, Ji CL, Yang K, et al. Fatty oil from Securidaca inappendiculata exerted therapeutic effects on adjuvant-induced arthritis in mice via suppression on fibroblast-like synoviocyte. Kaohsiung J Med Sci. 2018;34:616–625.
   PubMed Web of Science ®Google Scholar
• Zuo J, Ji CL, Olatunji OJ, et al. Bioactive fractions from Securidaca inappendiculata alleviated collagen-induced arthritis in rats by regulating metabolism-related signaling. Kaohsiung J Med Sci. 2020;36:523–534.
   PubMed Web of Science ®Google Scholar
• Zuo J, Qin Q, Wang L, et al. Mangosteen ethanol extract alleviated the severity of collagen-induced arthritis in rats and produced synergistic effects with methotrexate. Pharm Biol. 2018;56:455–464.
   PubMed Web of Science ®Google Scholar
• Zuo J, Mao KJ, Yuan F, et al. Xanthones with anti-tumor activity isolated from Securidaca inappendiculata. Med Chem Res. 2014;23:4865–4871.
   Web of Science ®Google Scholar
• Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull Hosp Joint Dis. 2007;65:168–173.
   Google Scholar
• Keppeler G. Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients. J Pharm Sci. 2010;78:165–171.
   Google Scholar
• Furst DE. The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum. 2010;39:327–346.
   PubMed Web of Science ®Google Scholar
• Zuo J, Wang X, Liu Y, et al. Integrating network pharmacology and metabolomics study on anti-rheumatic mechanisms and antagonistic effects against methotrexate-induced toxicity of Qing-Luo-Yin. Front Pharmacol. 2018;2018:1472.
   Google Scholar
• Orr A, Parker R. Red clover causing symptoms suggestive of methotrexate toxicity in a patient on high-dose methotrexate. Menopause Int. 2013;19:133–134.
   PubMedGoogle Scholar
• Zuo J, Yin Q, Wang YW, et al. Inhibition of NF-κB pathway in fibroblast-like synoviocytes by α-mangostin implicated in protective effects on joints in rats suffering from adjuvant-induced arthritis. Int Immunopharmacol. 2018;56:78–89.
   PubMed Web of Science ®Google Scholar
• Xu WK, Jiang H, Yang K, et al. Development and in vivo evaluation of self-microemulsion as delivery system for α-mangostin. Kaohsiung J Med Sci. 2017;33:116–123.
   PubMed Web of Science ®Google Scholar
• Zuo J, Xia Y, Li X, et al. Selective modulation of MAPKs contribute to the anti-proliferative and anti-inflammatory activities of 1,7-dihydroxy-3,4-dimethoxyxanthone in rheumatoid arthritis-derived fibroblast-like synoviocyte MH7A cells. J Ethnopharmacol. 2015;168:248–254.
   PubMed Web of Science ®Google Scholar
• Zuo J, Dou DY, Wang HF, et al. Reactive oxygen species mediated NF-κB/p38 feedback loop implicated in proliferation inhibition of HFLS-RA cells induced by 1,7-dihydroxy-3,4-dimethoxyxanthone. Biomed Pharmacother. 2017;94:1002–1009.
   PubMed Web of Science ®Google Scholar
• Ji CL, Jiang H, Tao MQ, et al. Selective regulation of IKKβ/NF-κB pathway involved in proliferation inhibition of HFLS-RA cells induced by 1,7-dihydroxyl-3,4-dimethoxylxanthone. Kaohsiung J Med Sci. 2017;33:486–495.
   PubMed Web of Science ®Google Scholar
• Tao MQ, Ji CL, Wu YJ, et al. 1,7-dihydroxy-3,4-dimethoxyxanthone inhibits lipopolysaccharide-induced inflammation in raw264.7 macrophages by suppressing TLR4/NF-κB signaling cascades. Inflammation. 2020;43:1821–1831.
   PubMed Web of Science ®Google Scholar
• Tao M, Jiang J, Wang L, et al. α-mangostin alleviated lipopolysaccharide induced acute lung injury in rats by suppressing NAMPT/NAD controlled inflammatory reactions. Evid-Based Complementary Altern Med. 2018;2018:1–10.
   Web of Science ®Google Scholar
• Yang K, Yin Q, Mao Q, et al. Metabolomics analysis reveals therapeutic effects of α-mangostin on collagen-induced arthritis in rats by down-regulating nicotinamide phosphoribosyltransferase. Inflammation. 2019;42:741–753.
   PubMed Web of Science ®Google Scholar